Status:
COMPLETED
AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
20-45 years
Phase:
PHASE1
Brief Summary
A open label two way crossover formulation and food effect study in healthy volunteers to assess the pharmacokinetics of a single dose of AZD2066 new oral solid formulation and an oral solution
Eligibility Criteria
Inclusion
- Clinical normal physical findings, including BP, pulse rate \>45 bpm, ECG and laboratory assessments
- Body Mass Index (BMI) of ≥18 to ≤30 kg/m2 and weight of ≥50 to ≤100 kg
Exclusion
- History of hypersensitivity, allergy or atopic/skin disease as judged by Investigator.
- History of somatic or psychiatric disease/condition, which may interfere with the objectives of the study as judged by the Investigator.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00690404
Start Date
April 1 2008
End Date
June 1 2008
Last Update
December 10 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.